loader image

Eos Portfolio

Meet our inspiring founders. Companies are defined by people and their performance.

Eos first invested: August, 2023
Founder: Lee Cronin
Chemify is building the digital chemistry infrastructure to enable worldwide access to any desired compound instantly and on-demand
Eos first invested: June, 2023
Laverock Therapeutics is developing a unique gene silencing platform for the creation of programmable advanced therapies.
Eos first invested: April, 2023
Bioliberty creates soft robotics technology to provide social care services to improve patient outcomes.
Eos first invested: December, 2022
Founder: David McElroy Phd
Pioneering the discovery, development and sustainable production of high-value plant natural products
Eos first invested: September, 2022
Founder: Richard Hammond
Penrhos Bio offers Remora technology, inspired by nature, that protects against bacteria, fungi, and algae, to provide self-cleaning surfaces.
Eos first invested: June, 2022
Founder: Giovanna Laudisio
Biodegradable, sustainable and cost competitive cellulose microparticles to replace plastic microbeads
Eos first invested: April, 2022
Founder: Ishani Malhotra
Carcinotech is a MedTech company manufacturing 3D printed mini tumours developed from patient-specific cancer stem cells, primary cells and established cell lines.
Eos first invested: July, 2021
Founder: Richard Kuo
Specializes in maximizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers.
Eos first invested: December, 2020
Founder: Rotimi Alabi
Lab-on-a-chip’ technology that delivers oil analysis 1000x faster and 10x cheaper than the current ‘send the sample to laboratory approach.
Eos first invested: June, 2020
Founder: Clare Waring
Europes first cancer drug accelerator. Finding assets, creating spin-outs, commercialising cancer therapies.
Eos first invested: February, 2020
Novel Technologies has developed a technology where pure silver particles are incorporated into fibres as a antimicrobial coating for paints and textiles in a way that is ecologically sound and non-toxic to humans.
Eos first invested: January, 2020
Founder: Gavin Munro
Formed in 2014 to offer Adjusta-Cone® as the world’s first fully adjustable differential pressure cone meter for natural gas.
Eos first invested: October, 2019
Founder: Joel Watt
Connects seafood buyers and suppliers, giving them the right tools to trade efficiently, negotiate prices and process deliveries across Europe – all in real-time, 24/7.
Eos first invested: February, 2019
Founder: Dr Mark Hegarty
Offers a revolutionary spectroscopic liquid biopsy with artificial intelligence for the early detection of cancer and other diseases.
Eos first invested: April, 2018
Founder: Dr Dave Hughes
An award winning Scottish sensors company utilising thin-film processes to eliminate conventional limitations in ultrasound sensors.
Eos first invested: June, 2017
Founder: Jim Laird
ABUNDA mycoprotein is a fermented food ingredient, rich in protein and fibre. Naturally fortified in B12, zinc and iron. ABUNDA is highly nutritious.
Eos first invested: March, 2016
Founder: Prof. Ian A. Johnston
A provider of specialist genetics and breeding management services to the aquaculture industry.
Eos first invested: December, 2015
With minimal set-up and an intuitive web browser interface, their femtosecond lasers and picosecond OPOs, enable the scientific community and industrial partners to push boundaries and discover more.
Eos first invested: July, 2015
Founder: Prof. W. H. Stimson
An early stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for Virology, Cancer, Atopic Dermatitis and Psoriasis.

Latest news

Dxcover present clinical trial for the early detection of cancer at the American Association for Cancer Research
09 April 2024
Neupulse secures a £2.5 million investment led by Eos
18 March 2024

This website uses cookies to ensure you get the best experience on our website. By continuing to browse on this website, you accept the use of cookies for the above purposes.